These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10900040)

  • 1. Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex.
    Westra DF; Verjans GMGM; Osterhaus ADME; van Kooij A; Welling GW; Scheffer AJ; The TH; Welling-Wester S
    J Gen Virol; 2000 Aug; 81(Pt 8):2011-2015. PubMed ID: 10900040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
    Peng T; Ponce-de-Leon M; Jiang H; Dubin G; Lubinski JM; Eisenberg RJ; Cohen GH
    J Virol; 1998 Jan; 72(1):65-72. PubMed ID: 9420201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2.
    Carmack MA; Yasukawa LL; Chang SY; Tran C; Saldana F; Arvin AM; Prober CG
    J Infect Dis; 1996 Nov; 174(5):899-906. PubMed ID: 8896488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
    Hook LM; Huang J; Jiang M; Hodinka R; Friedman HM
    J Virol; 2008 Jul; 82(14):6935-41. PubMed ID: 18480440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.
    Torseth JW; Cohen GH; Eisenberg RJ; Berman PW; Lasky LA; Cerini CP; Heilman CJ; Kerwar S; Merigan TC
    J Virol; 1987 May; 61(5):1532-9. PubMed ID: 3033279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
    J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
    Criscuolo E; Castelli M; Diotti RA; Amato V; Burioni R; Clementi M; Ambrosi A; Mancini N; Clementi N
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Functional Interaction between Herpes Simplex Virus 1 Glycoprotein gH/gL Domains I and II and gD Is Defined by Using Alphaherpesvirus gH and gL Chimeras.
    Fan Q; Longnecker R; Connolly SA
    J Virol; 2015 Jul; 89(14):7159-69. PubMed ID: 25926636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.
    Novotny MJ; Parish ML; Spear PG
    Virology; 1996 Jul; 221(1):1-13. PubMed ID: 8661409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H.
    Roop C; Hutchinson L; Johnson DC
    J Virol; 1993 Apr; 67(4):2285-97. PubMed ID: 8383241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
    J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function analysis of herpes simplex virus type 1 gD and gH-gL: clues from gDgH chimeras.
    Cairns TM; Milne RS; Ponce-de-Leon M; Tobin DK; Cohen GH; Eisenberg RJ
    J Virol; 2003 Jun; 77(12):6731-42. PubMed ID: 12767993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Characterization of Glycoprotein H Chimeras Composed of Conserved Domains of the Pseudorabies Virus and Herpes Simplex Virus 1 Homologs.
    Böhm SW; Backovic M; Klupp BG; Rey FA; Mettenleiter TC; Fuchs W
    J Virol; 2016 Jan; 90(1):421-32. PubMed ID: 26491153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1.
    Rogalin HB; Heldwein EE
    J Virol; 2016 Nov; 90(22):10321-10328. PubMed ID: 27605677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic structure of soluble herpes simplex virus (HSV) glycoprotein D correlates with inhibition of HSV infection.
    Nicola AV; Peng C; Lou H; Cohen GH; Eisenberg RJ
    J Virol; 1997 Apr; 71(4):2940-6. PubMed ID: 9060653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
    Mikloska Z; Cunningham AL
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligomeric structure of glycoproteins in herpes simplex virus type 1.
    Handler CG; Eisenberg RJ; Cohen GH
    J Virol; 1996 Sep; 70(9):6067-70. PubMed ID: 8709230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.
    Önnheim K; Ekblad M; Görander S; Bergström T; Liljeqvist JÅ
    Viruses; 2016 Apr; 8(4):110. PubMed ID: 27110813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.